IP Library Granted Patent US 8,784,409
Granted Patent B2
US 8,784,409 · App. 13/061,171 · Granted Jul 22, 2014

Cryogenic system and method of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,784,409
App. No.
13/061,171
Granted
Jul 22, 2014
Kind
B2
Abstract

A cryogenic medical device for delivery of subcooled liquid cryogen to various configurations of cryoprobes is designed for the treatment of damaged, diseased, cancerous or other unwanted tissues. The device is a closed or semi-closed system in which the liquid cryogen is contained in both the supply and return stages. The device is capable of generating cryogen to a supercritical state and may be utilized in any rapid cooling systems. As designed, the device comprises a number of parts including a vacuum insulated outer dewar, submersible cryogen pump, baffled linear heat exchanger, multiple pressurization cartridges, a return chamber, and a series of valves to control the flow of the liquid cryogen interconnected with cryotreatment devices including cryoprobes and catheters. The cryogenic medical device promotes subcooling to the tips of various external cryogenic instrument configurations.

Claims (43)

1. A cryogenic system comprising:

a container having cryogen within said container;

one or more cryoprobes outside said container for use in cryotherapeutic procedures, said one or more cryoprobes having a distal freeze zone;

at least one pressurized apparatus having one or more heaters arranged therein to form a pressurized cryogen, said pressurized apparatus having at least one port, and one or more control valves; at least a first portion of said pressurized apparatus submersed in the cryogen and having a first temperature, and at least a second portion of said pressurized apparatus positioned outside the cryogen and having a second temperature greater than said first temperature; wherein said pressurized apparatus generates a pressurized cryogen and is capable of generating compressed liquid cryogen, critical cryogen, pseudo-fluidic cryogen or supercritical cryogen. a cryogenic pump submersed within the cryogen which delivers the cryogen to said port of said pressurized apparatus through at least one fill line, said fill line including a valve which opens to deliver the cryogen to said port of said pressurized apparatus and closes once said pressurized apparatus is filled to a specified level;

at least one supply line connecting said pressurized apparatus to said one or more cryoprobes and directing said pressurized cryogen through to said one or more cryoprobes to said distal freeze zone; and

at least one return line which returns the cryogen from said distal freeze zone of said one or more cryoprobes to said container or to a subcooling chamber;

wherein said pressurized apparatus is configured to provide controlled continuous delivery of said pressurized cryogen to said distal freeze zone of said one or more cryoprobes, said controlled continuous delivery configured for manual and remote control operation.

2. The cryogenic system of claim 1 , wherein one or more manifolds direct a flow of the cryogen through to said one or more cryoprobes to target cardiac tissue, cancerous tissue, undesired tissue, or irregularities; said one or more manifolds comprising an integral assembly for directing at least a first composition or at least a second composition, alone or in combination, wherein said first composition is a liquid and said second composition is a gas.

3. The cryogenic system of claim 2 , further comprising a control mechanism for varying the temperature or pressure of said first composition and said second composition, alone or in combination.

4. The cryogenic system of claim 1 , wherein two or more of said pressurized apparati are configured to provide a sequential delivery of said pressurized cryogen.

5. The cryogenic system of claim 1 , wherein said one or more cryoprobes comprises a condensation based vacuum insulated catheter including:

one or more cryogenic lines internal to said condensation based vacuum insulated catheter and having an outer surface with enhanced nucleation sites;

an outer sheath encasing said cryogenic lines and having a lumen therein filled with vapors that remain in a gaseous state at an ambient temperature and solidify upon cooling; and

a formation of solid crystals along said outer surface of said one or more cryogenic lines and having low thermal conductivity;

wherein said formation of solid crystals upon said enhanced nucleation sites creates an evacuated space within said lumen.

6. The cryogenic system of claim 5 , wherein said evacuated space is an insulative vacuum formed from non-equilibrating phase change gas and said insulative vacuum is dependent on temperature reduction of said non-equilibrating phase change gas, said non-equilibrating phase change gas precipitating out of said lumen and solidifying upon said outer surface of said one or more cryogenic lines.

7. The cryogenic system of claim 1 , wherein said one or more cryoprobes comprise a monitoring element, a sensor, or an optical imaging component, one or more thermocouples, an electrocardiogram monitor, one or more pressure transducers, and an electrophysiological sensor, individually or in any combination.

8. The cryogenic system of claim 1 , wherein said one or more cryoprobes is rigid or flexible and directed to a target tissue site for a selected cryotherapeutic procedure, said one or more cryoprobes capable of being activated individually or collectively to produce a desired temperature or freeze duration.

9. The cryogenic system of claim 1 , wherein said first portion and said second portion of said pressurized apparatus are individual interconnected pressurization chambers comprising a first pressurization chamber inside said container of the cryogen and a second pressurization chamber outside of the cryogen.

10. The cryogenic system of claim 1 , further comprising a baffled linear heat exchanger.

11. The cryogenic system of claim 10 , wherein said baffled linear heat exchanger is surrounded by a subcooling chamber or a cryogen reservoir.

12. The cryogenic system of claim 1 , wherein the cryogen is nitrogen and said pressurized apparatus forms supercritical nitrogen.

13. The cryogenic system of claim 1 , wherein said one or more cryoprobes comprises:

an outer sheath forming a longitudinal body having a proximal end and a closed distal end such that a lumen is created therebetween;

two or more cryogenic lines positioned in parallel or co-axially within said lumen and having an open-ended configuration at said closed distal end of said longitudinal body, said two or more cryogenic lines interconnected with said supply lines and said return lines such that delivery of said pressurized cryogen to said closed distal end of said longitudinal body creates said distal freeze zone; and

a vacuum created in said lumen around and between said cryogenic lines;

wherein said distal freeze zone is a linear configuration, a curved linear configuration, or a spot freeze zone.

14. The cryogenic system of claim 13 , wherein said open-ended configuration of said two or more cryogenic lines is linked to form a unitary structure at said closed distal end.

15. The cryogenic system of claim 14 , wherein said unitary structure forms a closed loop tip, a closed loop coil with or without an internal heat exchanger, an inflatable cryogenic element, or a configuration which creates an isolated freeze zone.

16. The cryogenic system of claim 13 , wherein said distal freeze zone is an inflatable cryogenic element in the configuration of a balloon.

17. A method of delivering cryogen to a cryoprobe utilizing the cryogenic system of claim 1 , said method comprising the steps of:

filling a first portion of said one or more pressurized apparati;

activating said one or more pressurized apparati to form a supercritical cryogen; and

controllably directing said pressurized cryogen to said one or more cryoprobes through said one or more supply lines and from said instrument through said one or more return lines;

wherein said step of activating said one or more pressurized apparati includes a step of pressurizing each of said pressurized apparati and releasing said pressurized cryogen in a controlled continual sequence.

18. A cryogenic system comprising:

a cryogen reservoir filled with a cryogen;

one or more cryoprobes outside said cryogen reservoir, said one or more cryoprobes having a distal freeze zone;

at least a first pressurization chamber and a second pressurization chamber linked together, each comprising: one or more heaters arranged therein to form a pressurized cryogen, one or more ports, and one or more control valves;

a cryogenic pump submersed within the cryogen which delivers the cryogen to at least one of said one or more ports;

at least one supply line connecting said first pressurization chamber to said one or more cryoprobes and directing said pressurized cryogen through to said distal freeze zone; and

at least one return line which returns the cryogen from said distal freeze zone of said one or more cryoprobes to said cryogen reservoir;

wherein said first pressurization chamber is submersed in said cryogen reservoir and having a first temperature, and said second of said pressurization chambers is positioned outside the cryogen and having a second ambient temperature greater than said first temperature to generate a supercritical cryogen.

Assignments (11)
RELEASE OF SECURITY INTEREST Recorded Aug 29, 2025
From: MIDCAP FINANCIAL TRUST
To: HEALTHTRONICS, INC., C/O JACKSON WALKER LLP; ENDOCARE, INC.
Reel/Frame 072776/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2021
From: ENDOCARE
To: VARIAN MEDICAL SYSTEMS, INC.
Reel/Frame 055740/0029 →
RELEASE OF SECURITY INTEREST Recorded Jul 5, 2018
From: REGIONS BANK
To: ENDOCARE, INC.; HEALTHTRONICS, INC.
Reel/Frame 046500/0151 →
RELEASE OF SECURITY INTEREST Recorded Jun 26, 2018
From: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
To: ENDOCARE, INC.
Reel/Frame 046429/0787 →
SECURITY INTEREST Recorded Mar 11, 2016
From: HEALTHTRONICS, INC.; ENDOCARE, INC.
To: MIDCAP FINANCIAL TRUST, AS ADMINISTRATIVE AGENT
Reel/Frame 038063/0201 →
SECURITY AGREEMENT Recorded Feb 28, 2014
From: ENDOCARE, INC.
To: REGIONS BANK
Reel/Frame 032372/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2013
From: ENDO PHARMACEUTICALS INC.
To: ENDOCARE, INC.
Reel/Frame 031132/0929 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2013
From: ENDO PHARMACEUTICALS INC.
To: ENDOCARE, INC.
Reel/Frame 030690/0015 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2012
From: CPSI HOLDINGS LLC
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 027794/0791 →
CORRECTIVE ASSIGNMENT TO CORRECT THE [REMOVAL] OF AN ASSIGNOR AND CORRECT "CORRESPONDENT NAME" PREVIOUSLY RECORDED ON REEL 027154 FRAME 0778. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 29, 2011
From: BAUST, JOHN M.; CHEEKS, ROY E.; BAUST, JOHN G.; ROBILOTTO, ANTHONY; SNYDER, KRISTI K.
To: CPSI HOLDINGS LLC
Reel/Frame 027290/0244 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2011
From: BAUST, JOHN M; ROBILOTTO, ANTHONY; SNYDER, KRISTI K.; CHEEKS, ROY; VAN BUSKIRK, ROBERT; BAUST, JOHN G.; DOBSON, MELISSA K.; CORWIN, WIL
To: CPSI HOLDINGS LLC
Reel/Frame 027154/0778 →